nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis
|
Saida, T |
|
2012 |
18 |
9 |
p. 1269-1277 |
artikel |
2 |
Assessing brain connectivity at rest is clinically relevant in early multiple sclerosis
|
Faivre, Anthony |
|
2012 |
18 |
9 |
p. 1251-1258 |
artikel |
3 |
Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality
|
Kim, Su-Hyun |
|
2012 |
18 |
9 |
p. 1340-1343 |
artikel |
4 |
Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada
|
Saeedi, Jameelah |
|
2012 |
18 |
9 |
p. 1239-1243 |
artikel |
5 |
Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture–recapture method
|
El Adssi, Haritina |
|
2012 |
18 |
9 |
p. 1244-1250 |
artikel |
6 |
Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis
|
Kümpfel, T |
|
2012 |
18 |
9 |
p. 1229-1238 |
artikel |
7 |
High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women
|
Hedström, Anna K |
|
2012 |
18 |
9 |
p. 1334-1336 |
artikel |
8 |
Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort
|
Lebrun, C |
|
2012 |
18 |
9 |
p. 1297-1302 |
artikel |
9 |
Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis
|
Klawiter, Eric C |
|
2012 |
18 |
9 |
p. 1259-1268 |
artikel |
10 |
Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: Commentary
|
Hutchinson, Michael |
|
2012 |
18 |
9 |
p. 1213-1214 |
artikel |
11 |
Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: No
|
Weinshenker, Brian G |
|
2012 |
18 |
9 |
p. 1211-1212 |
artikel |
12 |
Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: Yes
|
Havrdová, Eva |
|
2012 |
18 |
9 |
p. 1209-1210 |
artikel |
13 |
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years
|
Confavreux, Christian |
|
2012 |
18 |
9 |
p. 1278-1289 |
artikel |
14 |
MRI-based analysis of the natalizumab therapeutic window in multiple sclerosis
|
Grimaldi, Luigi ME |
|
2012 |
18 |
9 |
p. 1337-1339 |
artikel |
15 |
Multiple sclerosis and progressive resistance training: a systematic review
|
Kjølhede, T |
|
2012 |
18 |
9 |
p. 1215-1228 |
artikel |
16 |
Platform Presentations
|
|
|
2012 |
18 |
9 |
p. S5-S10 |
artikel |
17 |
Poster Presentations
|
|
|
2012 |
18 |
9 |
p. S10-S23 |
artikel |
18 |
Prelims for ACTRIMS
|
|
|
2012 |
18 |
9 |
p. 1345-1346 |
artikel |
19 |
Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials
|
Benedict, Ralph HB |
|
2012 |
18 |
9 |
p. 1320-1325 |
artikel |
20 |
Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia
|
Marrie, Ruth Ann |
|
2012 |
18 |
9 |
p. 1310-1319 |
artikel |
21 |
The relation between cognitive and motor dysfunction and motor imagery ability in patients with multiple sclerosis
|
Heremans, Elke |
|
2012 |
18 |
9 |
p. 1303-1309 |
artikel |
22 |
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome
|
Young, CA |
|
2012 |
18 |
9 |
p. 1326-1333 |
artikel |
23 |
Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing multiple sclerosis: A systematic review and meta-analysis
|
Nicholas, Richard |
|
2012 |
18 |
9 |
p. 1290-1296 |
artikel |
24 |
Trigger, pathogen, or bystander: the complex nexus linking Epstein– Barr virus and multiple sclerosis
|
Owens, Gregory P |
|
2012 |
18 |
9 |
p. 1204-1208 |
artikel |